http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114380687-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d99a53d1f5fd04fb37ecc4ba35f9994c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C62-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C62-34
filingDate 2020-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cf7232bf502a220ee9dedaf6c8f1f44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fed9c303bb14ae6e89afcdaa25dc5e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eb57a173962b9bfd65c1881d70dccb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_089ed93d3d4239793bc3cf28d7d95832
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dfdbfd179503b02400bccdb1d274d3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34d896d1031a2918915735a243fa3b6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c2b2bb0d9881b21246e5bbb279bf521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9a766b9b722f56449aff7e126510505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5644453bc87bdda845531abcfeb6bfb6
publicationDate 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114380687-A
titleOfInvention Preparation and application of new lignan compounds in Angelica sinensis
abstract The invention belongs to the technical field of medicine, discloses the preparation and use of neolignans in Angelica sinensis, and specifically relates to the remarkable sedative and hypnotic effects of new neolignans compounds. The results of animal experiments proved that compounds (+)‑1 and (‑)‑1 have obvious sedative and hypnotic effects, and are expected to be therapeutic drugs for mental diseases related to insomnia, convulsions, epilepsy/anxiety and depression.
priorityDate 2020-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451679761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408196011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452764334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453266603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID969472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454715251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448981304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415731140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208902
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID673473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415830121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408839960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448989919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21879635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452041512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54691413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419528643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23692753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412510160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10220503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6885
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426387251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24965990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43834305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5732
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18373917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419594533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18681192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22242641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5319022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6850754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419542780

Total number of triples: 83.